THE Ukrainian Football Association have refused to comment on a report that Chelsea winger Mykhailo Mudryk came into contact with a medication that boosts breathing capacity and stamina while on international duty.
Mudryk, 24, was provisionally suspended in December 2024 after the English Football Association charged him with a doping offence.
The Blues signed Mudryk from Shakhtar Donetsk for £60million in January 2023.
BBC Sport has reported that Mudryk “came into contact with the cardiovascular medication meldonium” and asked the UAF for verification.
“UAF officials cannot comment on this matter, since the UAF is not a part of this case,” they said.
“The World Anti-Doping Energy (Wada) or the English FA didn’t send any request to the UAF.
“We are in close contact with Mudryk’s lawyers and provide them with all necessary information. We cannot comment further, as a non-disclosure provision is in effect.
“No UAF official, staff, doctors, or coach were involved.”
Mudryk has made 73 appearances for Chelsea and scored ten goals. His last appearance was away to Heidenheim in the Europa Conference League on November 28, 2024, when he scored in a 2-0 win.
Ukrainian side Shakhtar could lose £26million in add-ons that was agreed in the transfer.
Shakhtar chief executive Sergei Palkin has denied the club are considering suing the UAF.
The club’s sporting director Dario Srna told BBC Sport: “When we speak about Mudryk, we don’t think about the money, we speak about the human being.
“We feel so sorry for him. We know he is 100 per cent innocent – he will show that.
“We support him like an ex-player, a human being and a friend.
“We don’t think the money is important.”
